Pear Therapeutics, Inc. - Class A Common Stock (NQ: PEAR )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 18, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pear Therapeutics, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Pear Presents Interim Real-World Data Showing Significant Reductions in Symptoms of Chronic Insomnia, Anxiety and Depression with Somryst® at SLEEP 2022
From Pear Therapeutics, Inc.
Via Business Wire
95 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II... 
Via Benzinga
Mid-Afternoon Market Update: Dow Turns Lower; DiDi Global Shares Surge
U.S. stocks pared gains, with the Dow Jones turning lower toward the end of trading on Monday. 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Mid-Day Market Update: Nasdaq Rises 1%; Praxis Precision Medicines Shares Plunge
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Monday. 
Via Benzinga
Pear Therapeutics Announces New Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Using reSET® at Six Months
From Pear Therapeutics, Inc.
Via Business Wire
Earnings Scheduled For May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand. 
Via Benzinga
52 Stocks Moving In Monday's Mid-Day Session
Gainers DiDi Global Inc. (NYSE: DIDI) jumped 51.4% to $2.80 after the Chinese government said the company can resume adding new users. 
Via Benzinga
Pear Therapeutics to Participate in the Jefferies Healthcare Conference
From Pear Therapeutics, Inc
Via Business Wire
69 Biggest Movers From Friday
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per... 
Via Benzinga
Pear Announces Health Equity Data Showing Similar Engagement with reSET-O® Across US Geographic Regions Presented at APA Annual Meeting
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics to Host Inaugural Virtual Investor Day on June 6, 2022
From Pear Therapeutics, Inc.
Via Business Wire
Chardan Capital Maintains Buy Rating for Pear Therapeutics: Here's What You Need To Know
Chardan Capital has decided to maintain its Buy rating of Pear Therapeutics (NASDAQ:PEAR) and lower its price target from $16.00 to $13.00. Shares of Pear Therapeutics are trading up 9.75% over the... 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Citigroup cut the price target on Insulet Corporation (NASDAQ: PODD) from $350 to $310. Insulet shares fell 1.1% to close at $196.91 on Monday. 
Via Benzinga
Pear Therapeutics Reports First Quarter 2022 Financial Results
From Pear Therapeutics, Inc.
Via Business Wire
90 Biggest Movers From Yesterday
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered... 
Via Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering. 
Via Benzinga
Pear Therapeutics Announces the Inclusion of QuickMD in Its Telehealth Provider Experience Initiative
From Pear Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Pear Therapeutics to Participate in the 17th Annual Needham Technology & Media Conference
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics to Participate in the Bank of America 2022 Healthcare Conference
From Pear Therapeutics, Inc.
Via Business Wire
90 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Pear Therapeutics to Issue First Quarter 2022 Financial Results on Monday, May 16, 2022
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics to Present at 2022 Rx and Illicit Drug Summit
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics Receives Safer Technologies Program (STeP) Designation from FDA for Product Candidate to Treat Acute and Chronic Pain
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics to Participate in Upcoming Investor Conferences
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics Announces Program to Bring Prescription Digital Therapeutics to Patients in Recovery Through a Telehealth Provider Experience
From Pear Therapeutics, Inc.
Via Business Wire
Pear Therapeutics to Participate in Upcoming Investor Event Hosted by Credit Suisse
From Pear Therapeutics, Inc.
Via Business Wire
51 Biggest Movers From Yesterday
Gainers Forge Global Holdings, Inc. (NYSE: FRGE) jumped 73.9% to close at $37.64. Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 60.5% to close at $4.14 on Wednesday... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.